farnaz shokraneh | personalized medicine | Best Researcher Award

Posted on by ScienceFather

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Ă…bo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

đź’Ľ Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

đź“–Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005

Sathiyanarayanan Lohidasan – Life sciences – Pharmaceutical sciences – Best Researcher Award 

Posted on by ScienceFather

Dr Sathiyanarayanan Lohidasan - Life sciences - Pharmaceutical sciences - Best Researcher Award 

Poona College of Pharmacy - India

Author Profile

Early Academic Pursuits

Dr. L. Sathiyanarayanan commenced his academic journey with a Bachelor's degree in Pharmacy from K.M. College of Pharmacy, Uthangudi, Madurai, affiliated with The Tamil Nadu Dr.MGR Medical University, Chennai. He achieved a notable score of 63.42% in 2000. His pursuit of higher education led him to earn a Master's in Pharmacy (Pharmaceutical Chemistry) from College of Pharmacy, SRIPMS, Coimbatore, in 2002, securing 65%. Subsequently, he completed his Ph.D. in 2010 from Poona College of Pharmacy, Pune, Maharashtra, affiliated with Bharati Vidyapeeth Deemed University, Pune.

Professional Endeavors

With an impressive 15-year teaching tenure spanning from 2002 to 2017, Dr. Sathiyanarayanan showcased his dedication to academia. His roles ranged from a Lecturer at APMC College of Pharmaceutical Education & Research, Gujarat, to positions at renowned institutions like The Oxford College of Pharmacy, Bangalore, and Bharati Vidyapeeth’s Poona College of Pharmacy, Pune, where he has served as an Associate Professor since June 2010.

Contributions and Research Focus

Dr. Sathiyanarayanan's research journey, spanning 14 years from 2003 to 2017, revolves around the application of analytical techniques in herbal drug development. His primary research areas include herbal standardization, herb-drug interactions, and the analysis of pharmaceuticals. He has particularly focused on preformulation studies and phytoformulations development. His Ph.D. thesis, titled 'Comparative evaluation of Ayurvedic ghrita and lipid-soluble extracts of selected herbals,' epitomizes his commitment to herbal sciences.

Accolades and Recognition

The academic and research community has recognized Dr. Sathiyanarayanan's contributions through numerous awards and grants. Notably, he was honored with the Bharati Vidyapeeth Deemed to be University Poona College of Pharmacy’s Pharmacy Teacher of the Year award by the Association of Pharmaceutical Teachers of India (APTI). His accolades also include the SFE Special recognition award, IASTAM Baityanath Award, and several research grants from esteemed institutions like the National Medicinal Plant Board and DST.

Impact and Influence

With an h-index of 25 and an i-10 index of 43, Dr. Sathiyanarayanan's research has garnered significant attention, evident from 1,755 citations across his 82 publications. His expertise in pharmaceutical sciences, particularly in herbal drug development, has had a profound impact on the field, shaping methodologies and contributing to advancements in the application of analytical techniques.

Legacy and Future Contributions

Dr. Sathiyanarayanan's legacy is marked by his pioneering research, guidance to numerous Ph.D. and PG students, and authorship of impactful books in pharmaceutical analysis. His future contributions are anticipated to further bridge the gap between traditional herbal medicine and modern pharmaceutical sciences, fostering innovative solutions for healthcare challenges. As an approved research guide and a recipient of multiple grants, Dr. Sathiyanarayanan continues to inspire the next generation of researchers and contribute significantly to the field of pharmaceutical sciences.

Notable PublicationÂ